JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 13, Issue 4 (2021)
Iran J War Public Health 2021, 13(4): 283-288 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2021/12/19 | Accepted: 2021/12/31 | Published: 2022/02/5
Received: 2021/12/19 | Accepted: 2021/12/31 | Published: 2022/02/5
How to cite this article
Ali Al Shammary S, Ibrahim Hussein I. Guillain-Barré Syndrome; a Neurological Disease during Convalescence Period. Iran J War Public Health 2021; 13 (4) :283-288
URL: http://ijwph.ir/article-1-1084-en.html
URL: http://ijwph.ir/article-1-1084-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
S.H. Ali Al Shammary *1, I. Ibrahim Hussein1
1- Physiology Department, Al Mustansiriya College of Medicine, Al Mustansiriya University, Baghdad, Iraq
Abstract (1116 Views)
Aims: Coronavirus can attack the central and peripheral nervous systems in different ways and produce neurological manifestations. This study aimed to summarize the neurological manifestations and electrophysiological studies of COVID-19 patients during the recovery phase, suggesting Guillain-Barré syndrome.
Patients & Methods: This case report study was done in the Department of Physiology, College of Medicine at Al-Mustansiriya University, in cooperation with Al-Yarmouk Teaching Hospital in Baghdad. Patients during the convalescent period (1-3 months post-infection) of COVID-19 disease with neurological manifestations were included. Neurologists and neurosurgeons referred the patients for an electromyography and nerve conduction study to identify their illnesses.
Findings: Seven patients (4 females and 3 males) presented with clinical manifestations that highly suggested Guillain-Barré syndrome. The patients were presented with a rapidly progressive ascending weakness of both lower and upper limbs and diffuse, hypo-or-areflexia of the deep tendon reflexes. The sensory symptoms were distributed in both hands and feet, pain, paresthesia, and numbness. Electrophysiology studies confirmed five patients have acute inflammatory demyelinating polyradiculoneuropathy, one patient has acute motor axonal neuropathy, and one has acute motor and sensory axonal neuropathy subtypes.
Conclusion: Clinical manifestations of Guillain-Barré syndrome confirmed by electrophysiological studies are associated with COVID-19, which show similarity with GBS due to the post-viral infections with an autoimmune background. Therefore coronavirus infection is an etiological factor of Guillain-Barré syndrome.
Patients & Methods: This case report study was done in the Department of Physiology, College of Medicine at Al-Mustansiriya University, in cooperation with Al-Yarmouk Teaching Hospital in Baghdad. Patients during the convalescent period (1-3 months post-infection) of COVID-19 disease with neurological manifestations were included. Neurologists and neurosurgeons referred the patients for an electromyography and nerve conduction study to identify their illnesses.
Findings: Seven patients (4 females and 3 males) presented with clinical manifestations that highly suggested Guillain-Barré syndrome. The patients were presented with a rapidly progressive ascending weakness of both lower and upper limbs and diffuse, hypo-or-areflexia of the deep tendon reflexes. The sensory symptoms were distributed in both hands and feet, pain, paresthesia, and numbness. Electrophysiology studies confirmed five patients have acute inflammatory demyelinating polyradiculoneuropathy, one patient has acute motor axonal neuropathy, and one has acute motor and sensory axonal neuropathy subtypes.
Conclusion: Clinical manifestations of Guillain-Barré syndrome confirmed by electrophysiological studies are associated with COVID-19, which show similarity with GBS due to the post-viral infections with an autoimmune background. Therefore coronavirus infection is an etiological factor of Guillain-Barré syndrome.
Keywords:
References
1. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-60. [Link]
2. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-92.e6. [Link] [DOI:10.1016/j.cell.2020.02.058] [PMID] [PMCID]
3. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R373-81 [Link] [DOI:10.1152/ajpregu.00292.2006] [PMID] [PMCID]
4. Swanson PA 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44-54. [Link] [DOI:10.1016/j.coviro.2014.12.009] [PMID] [PMCID]
5. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995-8. [Link] [DOI:10.1021/acschemneuro.0c00122] [PMID] [PMCID]
6. Abdennour L, Zeghal C, Dème M, Puybasset L. Interaction cerveau-poumon [Interaction brain-lungs]. Ann Fr Anesth Reanim. 2012;31(6):e101-7. [Link] [DOI:10.1016/j.annfar.2012.04.013] [PMID]
7. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020;126(10):1456-74. [Link] [DOI:10.1161/CIRCRESAHA.120.317015] [PMID] [PMCID]
8. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-34. [Link] [DOI:10.1016/S0140-6736(20)30628-0]
9. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386. [Link] [DOI:10.3389/fncel.2018.00386] [PMID] [PMCID]
10. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. [Link] [DOI:10.1001/jamaneurol.2020.1127] [PMID] [PMCID]
11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. [Link] [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. [Link] [DOI:10.1016/S0140-6736(20)30211-7]
13. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115-9. [Link] [DOI:10.1016/j.bbi.2020.04.077] [PMID] [PMCID]
14. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913-21. [Link] [DOI:10.1128/JVI.74.19.8913-8921.2000] [PMID] [PMCID]
15. Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113(1 Pt 1):e73-6. [Link] [DOI:10.1542/peds.113.1.e73] [PMID]
16. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119-20. [Link] [DOI:10.1148/radiol.2020201187] [PMID] [PMCID]
17. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204-7. [Link] [DOI:10.1111/jns.12382] [PMID] [PMCID]
18. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020;19(5):383-4. [Link] [DOI:10.1016/S1474-4422(20)30109-5]
19. Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989;12(6):435-51. [Link] [DOI:10.1002/mus.880120602] [PMID]
20. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-27. [Link] [DOI:10.1016/S0140-6736(16)00339-1]
21. Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol. 2004;115(10):2329-35. [Link] [DOI:10.1016/j.clinph.2004.05.009] [PMID]
22. Talukder RK, Sutradhar SR, Rahman KM, Uddin MJ, Akhter H. Guillian-Barre syndrome. Mymensingh Med J. 2011;20(4):748-56. [Link]
23. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020;77:8-12. [Link] [DOI:10.1016/j.jocn.2020.05.017] [PMID] [PMCID]
24. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-83. [Link] [DOI:10.1038/s41582-019-0250-9] [PMID] [PMCID]
25. Paybast S, Gorji R, Mavandadi S. Guillain-barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist. 2020;25(4):101-3. [Link] [DOI:10.1097/NRL.0000000000000291] [PMID] [PMCID]
26. El Otmani H, El Moutawakil B, Rafai MA, El Benna N, El Kettani C, Soussi M, et al. Covid-19 and Guillain-Barré syndrome: More than a coincidence!. Rev Neurol. 2020;176(6):518-9. [Link] [DOI:10.1016/j.neurol.2020.04.007] [PMID] [PMCID]
27. Christensen SK, Ballegaard M, Boesen MS. Guillian Barré syndromeafter mRNA-1273 vaccination against COVID-19. Ugeskr Laeger. 2021;183(35):V05210455. [Danish] [Link]
28. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22. [Link] [DOI:10.1016/j.bbi.2020.03.031] [PMID] [PMCID]
29. Nooshin A, Zahra G. COVID-19 and central nervous system. Entry Routes and Basic and Clinical Neuroscience. 11(3.Covid19). 217-22. [Link]
30. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. [Link] [DOI:10.1186/s40779-020-00240-0] [PMID] [PMCID]